Perrigo (NYSE:PRGO) Hits New 52-Week Low – What’s Next?

Perrigo Company plc (NYSE:PRGO)’s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $10.14 and last traded at $10.1530, with a volume of 725729 shares traded. The stock had previously closed at $10.72.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Weiss Ratings reissued a “sell (d+)” rating on shares of Perrigo in a research report on Monday, December 22nd. Jefferies Financial Group reiterated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Friday, February 13th. Finally, Canaccord Genuity Group reduced their price target on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, February 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Perrigo has an average rating of “Hold” and a consensus price target of $19.33.

Perrigo Trading Down 4.8%

The business’s 50 day moving average price is $14.19 and its two-hundred day moving average price is $16.99. The company has a market capitalization of $1.41 billion, a price-to-earnings ratio of -0.99, a P/E/G ratio of 1.29 and a beta of 0.41. The company has a current ratio of 2.76, a quick ratio of 1.63 and a debt-to-equity ratio of 1.23.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, February 26th. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.80 by ($0.03). The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. Perrigo’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.93 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 11.4%. The ex-dividend date is Monday, March 2nd. Perrigo’s payout ratio is -11.28%.

Institutional Investors Weigh In On Perrigo

Several hedge funds have recently added to or reduced their stakes in PRGO. Geneos Wealth Management Inc. increased its position in Perrigo by 439.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after acquiring an additional 786 shares during the period. Huntington National Bank increased its holdings in Perrigo by 237.8% in the second quarter. Huntington National Bank now owns 1,054 shares of the company’s stock valued at $28,000 after purchasing an additional 742 shares during the period. Kestra Investment Management LLC raised its position in Perrigo by 57.1% during the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after purchasing an additional 642 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in Perrigo by 89.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock worth $38,000 after buying an additional 838 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after buying an additional 1,014 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.